ODD

Analyst Note: Oddity Tech Ltd. (ODD)

Date: 2026-06-13 Current Price: $13.07

1. Structural Readiness

Conservative Entry: Not yet defined (awaiting breakout confirmation) Aggressive/Pre-Breakout Entry: N/A (Current price is not at a defined entry level for a confirmed breakout) Breakout Level: Not yet defined (Requires price to close above the resistance of the forming structure). Current Price: $13.07 Extension: N/A (Price has not yet broken out to generate an extension measurement).

Coil Classification: FORMING.

2. Thesis Layer

Thesis Status: TACTICAL / SETUP-LED There is no named secular thesis attached to this name as of 2026-06-13. The investment case is not driven by a macro secular theme (e.g., "AI Revolution" or "Green Energy Transition") but is strictly a tactical play on the structural setup quality and the company's specific business fundamentals. The conviction must be derived entirely from the strength of the setup (forming coil) and the operational evidence provided in the earnings and filings, without inventing a broader narrative.

3. Business Overview

Company: Oddity Tech Ltd. Industry: Consumer Technology / Beauty and Wellness (Digitally Native Brands). Business Model: The company operates as a consumer technology enterprise focused on developing and growing digitally native brands in the beauty and wellness sectors. It markets products directly to consumers, leveraging content creators and digital platforms.

Key Brands & Products:

• IL MAKIAGE: A flagship label featuring items for face, complexion, eyes, brows, lips, and general skincare.
• SpoiledChild: Specializes in hair and skin care solutions.
• METHODIQ: A medical telehealth platform designed to deliver high-efficacy treatments at scale, starting in dermatology. The product line spans 28 prescriptions and non-prescription products, including oral topical supplements and medical-grade makeup.

Operational Evidence (as of 2026-06-13):

• Revenue Guidance: Management expects to deliver $25 million in revenue for the current year (2026), citing the "strong success in year 1" of the SpoiledChild brand.
• Q2 Performance: For the second quarter of 2026, management expects net revenue to decline between 25% and 30% year-over-year.
• Profitability: Despite the revenue decline, management expects adjusted EBITDA for Q2 to be between $8 million and $10 million.
• Full Year Outlook: Management expects adjusted EBITDA for the full year 2026 to be positive.
• Customer Economics: Repeat sales represented approximately 2/3 (66%) of net revenue in the current quarter, up from 56% in Q1 '25.
• Challenges: Management explicitly states that "significant increases in customer acquisition costs" and "lower levels of customer acquisition" are impacting results. They note that if they had planned for these elevated CPA levels in 2026, they would have guided to a "normal earnings year of 20% revenue growth and 20% adjusted EBITDA margin." Instead, the current reality is a deleveraging on reduced revenue.

4. Archetype and Conviction

Archetype: Growth Leader (Transitioning / Restructuring) The company fits the "Growth Leader" archetype but is currently in a period of significant operational stress and restructuring. The business model relies on high-efficacy products and digital marketing, but the unit economics are currently under pressure due to external factors (elevated CPA).

Valuation & Financial Context:

• Financial Spine: Forward consensus EPS is projected at $0.12667 for FY1 and $1.02111 for FY2. This suggests a market expectation of a significant margin expansion or revenue recovery in the second year.
• ATR Context: The current ATR is 8.2%, classified as Extreme. In the StoryStocks canon, extreme ATR (>8%) correlates with the highest historical severe-loser rate. This indicates high volatility and significant risk in the current price action. The ATR at breakout is not yet defined as the breakout has not occurred.

Conviction Stack:

• Thesis Strength: Low (No named secular thesis; purely tactical).
• Evidence Quality: Moderate. The earnings transcript provides clear, specific guidance on revenue decline and EBITDA targets, but the narrative is one of "deleverage" and "adverse impact."
• Structural Quality: The setup is "Forming," which is a positive but incomplete signal. The high volatility (Extreme ATR) suggests the market is pricing in significant uncertainty.
• Setup Readiness: Partial. The price is holding above the support line, but the breakout has not fired.
• Rerating Potential: Dependent on the successful remediation of customer acquisition costs and the realization of the FY2 EPS growth.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Fundamental Deterioration: If management guidance for full-year positive EBITDA is missed, or if the "remedial actions" to lower CPA fail to show results in subsequent quarters.
• Acquisition Cost Persistence: If the "elevated acquisition costs" persist despite remediation, as warned in the March 2026 filing, the business model's growth prospects would be significantly adversely impacted.

What Would Strengthen the Case:

• Breakout Confirmation: A decisive close above the resistance level of the forming structure, accompanied by volume.
• Revenue Stabilization: Evidence that the 25-30% revenue decline is bottoming out and that the 2/3 repeat sales rate is sustainable or improving.
• EBITDA Beat: Actual Q2 or Full Year EBITDA exceeding the $8-10 million guidance range.

Gaps in Evidence:

• Breakout Level: The specific price target for the breakout is not defined.
• Remediation Details: While management mentions "remedial actions," the specific tactics or timeline for reducing CPA are not detailed in the provided evidence.
• MethodIQ Scale: While the platform is described, specific adoption metrics or revenue contribution from MethodIQ beyond the general "year 1 success" of SpoiledChild are not quantified in the provided text.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key evidence: Management guidance for positive full-year adjusted EBITDA despite 25-30% revenue decline; Repeat sales ratio improved to 66% from 56%; Forward consensus EPS projects significant growth in FY2 ($1.02). Key risks: Extreme ATR of 8.2% indicates severe volatility and high historical loss rate; Persistent elevated customer acquisition costs could prevent return to historical growth rates; Revenue decline in Q2 suggests near-term operational headwinds. Sizing hint: Position size should be minimal due to extreme volatility and unconfirmed setup; treat as a high-risk tactical observation rather than a core holding. Expected path: Management expects the business to become healthy and return to growth once acquisition costs normalize; the setup requires a confirmed breakout above the forming structure to validate the thesis. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation) and for management's remediation actions to show initial results.